Alyeska Investment Group, L.P. - VASCULAR BIOGENICS LTD ownership

VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 18 filers reported holding VASCULAR BIOGENICS LTD in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of VASCULAR BIOGENICS LTD
ValueSharesWeighting
Q2 2020$107,000
-4.5%
83,3330.0%0.00%0.0%
Q1 2020$112,000
+12.0%
83,3330.0%0.00%
+100.0%
Q4 2019$100,000
-10.7%
83,3330.0%0.00%
-50.0%
Q3 2019$112,000
+3.7%
83,3330.0%0.00%
+100.0%
Q2 2019$108,000
-15.0%
83,3330.0%0.00%
-50.0%
Q1 2019$127,000
+56.8%
83,3330.0%0.00%
+100.0%
Q4 2018$81,000
-40.0%
83,3330.0%0.00%0.0%
Q3 2018$135,000
-26.2%
83,3330.0%0.00%
-50.0%
Q2 2018$183,000
-4.7%
83,3330.0%0.00%0.0%
Q1 2018$192,000
-67.6%
83,3330.0%0.00%
-60.0%
Q4 2017$592,000
+16.5%
83,3330.0%0.01%
+25.0%
Q3 2017$508,000
+36.9%
83,3330.0%0.00%
+33.3%
Q2 2017$371,000
-19.0%
83,3330.0%0.00%
-25.0%
Q1 2017$458,000
+13.4%
83,3330.0%0.00%
+33.3%
Q4 2016$404,000
-7.1%
83,3330.0%0.00%
-25.0%
Q3 2016$435,000
+13.3%
83,3330.0%0.00%0.0%
Q2 2016$384,000
+32.4%
83,3330.0%0.00%
+33.3%
Q1 2016$290,000
-33.8%
83,3330.0%0.00%
-40.0%
Q4 2015$438,00083,3330.01%
Other shareholders
VASCULAR BIOGENICS LTD shareholders Q4 2015
NameSharesValueWeighting ↓
CVI Holdings, LLC 1,896,902$4,173,0005.19%
Knoll Capital Management, LLC 896,771$1,973,0001.68%
SABBY MANAGEMENT, LLC 1,856,169$4,084,0000.63%
683 Capital Management, LLC 346,574$762,0000.05%
Virtu Financial LLC 64,203$141,0000.01%
Spark Investment Management LLC 29,300$64,0000.00%
Alyeska Investment Group, L.P. 83,333$183,0000.00%
Burt Wealth Advisors 1,674$4,0000.00%
A.R.T. Advisors, LLC 24,682$54,0000.00%
GROUP ONE TRADING, L.P. 29,220$64,0000.00%
View complete list of VASCULAR BIOGENICS LTD shareholders